Pluri Inc. Files Q3 2024 10-Q Report

TL;DR

Pluri Inc. filed its 10-Q for Q3 2024. Check financials.

AI Summary

Pluri Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2024. The company, formerly known as Pluristem Therapeutics Inc., is incorporated in Nevada and operates in the biological products sector. Its business address is located at Matam Advanced Technology Park in Haifa, Israel.

Why It Matters

This filing provides investors with an update on Pluri Inc.'s financial performance and operational status for the third quarter of 2024, crucial for understanding the company's trajectory.

Risk Assessment

Risk Level: medium — As a biotechnology company, Pluri Inc. faces inherent risks related to research, development, regulatory approvals, and market adoption of its products.

Key Players & Entities

• Pluri Inc. (company) — Registrant
• September 30, 2024 (date) — Quarterly period end date
• Pluristem Therapeutics Inc. (company) — Former company name
• Nevada (jurisdiction) — State of incorporation
• Matam Advanced Technology Park (location) — Business address
• Haifa (location) — Business city

FAQ

Key Financial Figures

• $0.00001 — ch registered Common Shares, par value $0.00001 PLUR The Nasdaq Capital Market Securi
• $1 — ty $ 35,442 $ 39,527 (*) Less than $1 The accompanying notes are an integra
• $7 — had an accrued royalty in the amount of $7(see note 4). 10 PLURI INC. AND ITS S

Filing Documents

• ea0219288-10q_pluri.htm (10-Q) — 469KB
• ea021928801ex31-1_pluri.htm (EX-31.1) — 9KB
• ea021928801ex31-2_pluri.htm (EX-31.2) — 10KB
• ea021928801ex32-1_pluri.htm (EX-32.1) — 3KB
• ea021928801ex32-2_pluri.htm (EX-32.2) — 3KB
• 0001213900-24-096763.txt ( ) — 2888KB
• plur-20240930.xsd (EX-101.SCH) — 24KB
• plur-20240930_cal.xml (EX-101.CAL) — 31KB
• plur-20240930_def.xml (EX-101.DEF) — 131KB
• plur-20240930_lab.xml (EX-101.LAB) — 291KB
• plur-20240930_pre.xml (EX-101.PRE) — 153KB
• ea0219288-10q_pluri_htm.xml (XML) — 243KB

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT For the transition period from __________ to __________ Commission file number 001-31392 PLURI INC. (Exact name of registrant as specified in its charter) Nevada 98-0351734 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) MATAM Advanced Technology Park , Building No. 5 , Haifa , Israel 3508409 (Address of principal executive offices) (Zip Code) Registrant's telephone number 011-972-74-7108600 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Shares, par value $0.00001 PLUR The Nasdaq Capital Market Securities registered pursuant to Section 12(g) of the Act: None. (Title of class) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registration was required to submit files). Yes No Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No common shares issued and outstanding as of November 11, 2024. PART I – FINANCIAL INFORMATION Item 1. Financial Statements PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS As of September 30, 2024 U.S. DOLLARS IN THOUSANDS (Unaudited) INDEX Page Interim Condensed Consolidated Balance Sheets (Unaudited) 2-3 Interim Condensed Consolidated Statements of Operations (Unaudited) 4 Interim Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) 5-6 Interim Condensed Consolidated Statements of Cash Flows (Unaudited) 7 Notes to Interim Condensed Consolidated Financial Statements (Unaudited) 8-16 1 PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note September 30, 2024 June 30, 2024 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 3,198 $ 6,783 Short-term bank deposits 22,461 23,202 Restricted cash 365 254 Prepaid expenses and other current assets 1,008 868 Total current assets 27,032 31,107 LONG-TERM ASSETS: Restricted bank deposits 653 634 Severance pay fund 493 470 Property and equipment, net 846 688 Operating lease right-of-use asset 6,398 6,558 Other long-term assets 20 70 Total long-term assets 8,410 8,420 Total assets $ 35,442 $ 39,527 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 2 PLURI INC. AND ITS SUBSIDIARIES INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) U.S. Dollars in thousands (except share and per share data) Note September 30, 2024 June 30, 2024 LIABILITIES AND SHAREHOLDERS' EQUITY (DEFICIT) CURRENT LIABILITIES Trade payables $ 1,129 $ 964 Accrued expenses 1,103 1,223 Operating lease liability 574 559 Accrued vacation and recuperation 625 702 Other accounts payable 1,152 1,006 Total current liabilities 4,583 4,454 LONG-TERM LIABILITIES Accrued severance pay 619 605 Operating lease liability 4,938 5,026 Loan from the European Investment Bank, or EIB 4 25,365 24,027 Total long-term liabilities 30,922 29,658 COMMITMENTS AND CONTINGENCIES 3 SHAREHOLDERS' EQUITY (DEFICIT) Share capital: 5 Common shares, $ 0.00001 par value per share: Authorized: 37,500,00

View Full Filing

View this 10-Q filing on SEC EDGAR